相关实验视频

Updated: Sep 11, 2025

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Intramucosal Inoculation of Squamous Cell Carcinoma Cells in Mice for Tumor Immune Profiling and Treatment Response Assessment

Published on: April 22, 2019

在食道状细胞癌中新辅助免疫疗法的研究进展

Wenyuan Hong^1,2, Xuqiang Liao², Chaoyang Xia^1,2

¹Hainan Medical University, Haikou, China.

The American surgeon

|August 19, 2025

概括

新辅助性免疫疗法与化疗 (nICT) 结合,对食道状细胞癌 (ESCC) 显示出有前途. 本综述涵盖了nICT临床试验,新的策略和治疗切除ESCC的挑战.

科学领域:

在瘤学瘤学.
胃肠病学胃肠病学
免疫治疗是一种免疫疗法.

背景情况:

食道癌,特别是食道状细胞癌 (ESCC),是具有不良预后的侵略性.
目前的手术,放射治疗和化疗等治疗方法都有局限性,包括不令人满意的结果和耐药性.
新辅助免疫疗法与化疗结合 (nICT) 是可切除ESCC的新兴治疗策略.

研究的目的:

审查目前在可切除或可能切除的ESCC中对nICT的临床试验.
为ESCC提供前沿免疫治疗策略的概述.
识别和讨论ESCC在nICT中未解决的挑战.

主要方法:

临床试验的叙述性审查.
关于nICT在ESCC中的当前研究的摘要.
免疫治疗策略和挑战的分析.

主要成果:

越来越多的临床试验正在研究可切除ESCC中的nICT.
作为一种新的治疗方法,nICT的出现.
确定正在进行的研究和未来的方向.

结论:

nICT代表了可切除ESCC的新辅助治疗的重大进展.
需要进一步的研究来优化nICT战略并克服现有的挑战.
该评论强调了免疫疗法在食道癌症治疗中的不断变化的前景.

关键词:

食管状细胞癌的癌症免疫疗法免疫疗法在本地先进的先进.新辅助疗法是一种新辅助疗法.

更多相关视频

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

Subculture and Cryopreservation of Esophageal Adenocarcinoma Organoids: Pros and Cons for Single Cell Digestion

Published on: July 6, 2022

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Analysis of Human T Cell Activity in an Allogeneic Co-Culture Setting of Pre-Treated Tumor Cells

Published on: March 7, 2025

相关概念视频

Tumor Immunotherapy

Tumor Immunotherapy

Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.

Targeted Cancer Therapies

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...